Skip to main content
Livermore
Livermore
ZHEN

REGENXBIO Inc.

RGNX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001590877

In the last 90 days, REGENXBIO Inc. insiders filed 1 open-market purchase and 0 sales; 165 institutions reported holding it in 13F filings for Q2 2026, worth $504.6M in total; no superinvestor holds it.

Q2 2024 vs. Q1 2024

How the institutions holding REGENXBIO Inc. changed between Q1 2024 and Q2 2024.

All holders in Q2 2024All holders in Q1 2024

13F holders of RGNX: Q1 2024 compared with Q2 2024
MeasureQ1 2024Of which not filed for Q2 2024Q2 2024Change
Holders1882181−5
Shares42.6M42.1K43.8M+1.21M (+2.8%)
Value$896.6M$886.5K$511.9M−$383.8M (−42.8%)

2 institutions that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (25)

Institutions that held REGENXBIO Inc. at the end of Q2 2024 but not at the end of Q1 2024.

Institutions new to RGNX in Q2 2024
InstitutionSharesValue% of portfolio
Gsa Capital Partners LLP151,753$1.78M0.12%
Mirae Asset Global ETFs Holdings Ltd.109,725$1.28M0.00%
Jane Street Group, LLC94,970$1.11M0.00%
Allianz Asset Management GmbH92,600$1.08M0.00%
Jump Financial, LLC72,975$853.8K0.02%
UBS Oconnor LLC70,199$821.3K0.02%
Walleye Capital LLC55,576$650.2K0.01%
Acadian Asset Management LLC42,292$494.0K0.00%
Marshall Wace, LLP39,093$457.4K0.00%
Y-Intercept (Hong Kong) Ltd38,844$454.5K0.02%
Corebridge Financial, Inc.26,674$312.1K0.00%
Tudor Investment Corp Et Al26,407$309.0K0.00%
AQR Capital Management LLC20,379$238.4K0.00%
Engineers Gate Manager LP19,967$233.6K0.01%
Sherbrooke Park Advisers LLC15,857$185.5K0.03%
Brevan Howard Capital Management LP15,222$178.1K0.01%
Graham Capital Management, L.P.12,375$144.8K0.00%
Diversified Trust Co10,352$121.1K0.00%
Simplex Trading, LLC5,255$61.0K0.00%
Aquatic Capital Management LLC2,600$30.4K0.00%
nVerses Capital, LLC1,200$14.0K0.01%
Smartleaf Asset Management LLC97$1.13K0.00%
SRS Capital Advisors, Inc.23$2700.00%
Innealta Capital, LLC8$940.00%
Larson Financial Group LLC4$470.00%

Sold out (30)

Institutions that held REGENXBIO Inc. at the end of Q1 2024 and filed for Q2 2024 without it.

Institutions that sold out of RGNX in Q2 2024
InstitutionShares, Q1 2024Value, Q1 2024
Adage Capital Partners GP, L.L.C.165,073$3.48M
Affinity Asset Advisors, LLC110,000$2.32M
Susquehanna Fundamental Investments, LLC103,065$2.17M
Renaissance Technologies LLC97,500$2.05M
Exome Asset Management LLC84,470$1.78M
Liberty One Investment Management, LLC48,060$1.01M
Resolute Capital Asset Partners LLC40,000$843.0K
Ovata Capital Management Ltd40,000$842.8K
Texas Permanent School Fund35,204$741.7K
Campbell & CO Investment Adviser LLC34,041$717.2K
ExodusPoint Capital Management, LP22,744$479.0K
American International Group, Inc.22,128$466.2K
Prelude Capital Management, LLC21,565$454.4K
Cresset Asset Management, LLC17,731$373.6K
Dark Forest Capital Management LP12,984$273.6K
Bellevue Group AG12,000$252.8K
ProShare Advisors LLC11,384$239.9K
Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna4,000$80.8K
Metropolitan Life Insurance Co2,284$48.1K
Quantbot Technologies LP2,100$44.2K
KBC Group NV1,801$38.0K
Point72 Asset Management, L.P.1,600$33.7K
Quarry LP1,200$25.3K
Point72 Asia (Singapore) Pte. Ltd.928$19.6K
WR Wealth Planners, LLC192$4.04K
IFP Advisors, Inc125$2.63K
Riggs Asset Managment Co. Inc.34$717
Private Wealth Management Group, LLC27$569
Nelson, Van Denburg & Campbell Wealth Management Group, LLC8$168
Rothschild Investment LLC5$105

Not filed for Q2 2024 yet (2)

Institutions that held REGENXBIO Inc. at the end of Q1 2024 and haven't filed a 13F for Q2 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding RGNX in Q1 2024 that haven't filed for Q2 2024
InstitutionShares, Q1 2024Value, Q1 2024
Credit Suisse AG41,704$878.7K
Cambridge Trust Co370$7.80K